Kate Simon

Registered Genetic Counsellor

Kate received an MSc Distinction in Genetic Counselling at the University Hospital of Wales, Cardiff, in 2008. She has been a Genetic Counsellor within the North East Thames Regional Genetics Service since then, working at Southend University Hospital and Great Ormond Street Hospital.

Kate registered with the Genetic Counsellor Registration Board (GCRB) in 2012. The GCRB register is now held by the Academy for Healthcare Science (AHCS). She is a sign-off mentor for the GCRB and she has been the training officer/supervisor for numerous genetic counselling trainees and students.

Kate has a mixed clinical case load, including cancer, general and prenatal genetics. She is also currently involved in the differences of sexual development (DSD) specialist clinic. She was previously involved with the national retinoblastoma service. She has also been involved with mainstream education, helping to set up mainstream testing in Essex for Lynch syndrome and breast/ovarian cancer gene testing.

Specialisms

Areas of interest: Bowel cancer genetics, differences of sexual development, psychological aspects of having a genetic condition in the family

Selected puclications:

Poster Presentation: Simon K, Levene S, Thirlaway K (2008) Tay-Sachs disease: Knowledge and Interest in Carrier Testing amongst Ashkenazi Jewish Students. J Med Genet 45, Suppl 1: S111 (Abstracts of the British Society of Human Genetics Annual Conference, 2008)

My work contributed to a publication: Burton et al. (2009) Tay-Sachs Disease carrier screening in the Ashkenazi Jewish population. A needs assessment and review of current services. PHG Foundation, p70-72

Poster Presentation at British Society of Human Genetics Annual Conference, 2008: Simon K, Kumar AV, Side L (2010) Evaluation of tumour testing criteria for Lynch syndrome.

Spoken presentation at European Hereditary Tumour Group in Mallorca (2016) on Assessment of MUTYH Associated Polyposis (MAP) phenotype in order to refine testing guidelines

Poster Presentation at the World Congress in Genetic Counselling (2017) Assessment of MUTYH Associated Polyposis (MAP) phenotype in order to refine testing guidelines